HOME >> BIOLOGY >> NEWS
St. Jude ranked among top 500 supercomputer centers

collection to discovery of important new findings."

"The Hartwell Center is dedicated to research that will benefit children, and in the long run, the research will benefit all people who suffer from some of the same catastrophic diseases that threaten children around the world," Naeve said. "In that sense, although this is a St. Jude resource, it will produce knowledge that will be a resource for the entire world."

"Our goal is to help St. Jude use information technology to quicken the pace of clinical research into children's diseases," said James Coffin, Ph.D., vice president, IBM Life Sciences. "The selection of the right technology was very important to St. Jude because of the complexity of the projects and the volume of data that researchers are dealing with in their investigations. We are very pleased that they chose IBM's BladeCenter for their computing needs."

One of the St. Jude projects uses the new computing power to study the motion of enzyme molecules in order to determine how these proteins work, and how mutations in them change or destroy their ability to do their jobs, Naeve said. Enzymes are large proteins that control the speed of specific biochemical reactions in the body. Many diseases are caused by malfunctioning enzymes.

"Shape is everything to a protein," Naeve said. "Mutations that change a protein's shape can derail the protein's function and disrupt the normal function of the cell. And the shape of a potential drug molecule determines whether it will interact properly with its target in the body."

A second project that has benefited from the supercomputer is the study of the flexibility of a tumor suppressor protein called p27, and how the flexibility affects the protein's function. The supercomputer cut computation time from 200 hours to just 20. Another project that is benefiting from the supercomputer is a study that screens various molecules to determine if they might be effective drugs agai
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
22-Dec-2003


Page: 1 2 3

Related biology news :

1. Cleaner water, more efficient electricity among UH chemical research
2. Alcohol-use and depression among pregnant and postpartum women
3. Parents are top influence on soft-drink consumption among kids
4. University of Pittsburgh medical center among first to implant heart assist device
5. Professor and student among tops in technology at UH
6. UCSD study shows how we perceive world depends on precise division of labor among cells in brain
7. Chronic respiratory symptoms prevalent among Alaska natives
8. Specifying alcohol-related brain-damage among heavy social drinkers
9. Researchers identify unifying code among diverse classes of natural antibiotics
10. Marsupial among model organisms next in line for sequencing
11. Mastectomy dramatically reduces breast cancer risk among women with BRCA1/2 mutations

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the ... offering. ... report provides separate comprehensive analytics for the US, Japan ... Annual estimates and forecasts are provided for the period 2015 through ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... BEACH, Fla. , Feb. 16, 2017 /PRNewswire/ ... company revolutionizing the development of liquid biopsy tests ... has entered into an exclusive license agreement with ... distribute MDNA,s proprietary liquid biopsy test for prostate ... South Korea . This is the ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
Cached News: